Park, I., Shim, Y. S., Go, H., Hong, B. S., & Lee, J. L. (2019). Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures. BMC Urol.
Styl ChicagoPark, Inkeun, Young Sup Shim, Heounjeong Go, Bum Sik Hong, a Jae Lyun Lee. "Long-term Response of Metastatic Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome Associated Renal Cell Carcinoma to Bevacizumab Plus Erlotinib After Temsirolimus and Axitinib Treatment Failures." BMC Urol 2019.
Citace podle MLAPark, Inkeun, et al. "Long-term Response of Metastatic Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome Associated Renal Cell Carcinoma to Bevacizumab Plus Erlotinib After Temsirolimus and Axitinib Treatment Failures." BMC Urol 2019.